Michael C. Donegan, Principal Fin. and Accounting Officer at TherapeuticsMD, Inc. (TXMD), sold 1,309 shares at $5.34 ($7K) on 2023-01-23, disclosed to the SEC on 2023-01-25.
Open-market sale of $7k TXMD by Principal Fin. and Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.34 | 1,302 | $7K | 99.5% |
| 2 | $5.31 | 7 | $37 | 0.5% |
| Total | $5.34 avg | 1,309 | $7K | 100% |
| Filing → |
| TXMD | SELL | 2021-12-02 | $16K | — | Filing → |
| TXMD | SELL | 2021-05-12 | $5K | — | Filing → |